Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Lockdown in England could be extended, UK minister warns

Sun, 01st Nov 2020 09:54

* England's month-long lockdown could be extended, Gove says

* Health service would be overwhelmed without action now -
Gove

* Details of financial support to be announced in coming
days

* Labour's Starmer says UK spurned chance to lockdown
earlier

* JPMorgan sees economy shrinking 1.5% in Q4
(Updates death toll, adds JPMorgan forecast of economy)

By Andy Bruce

LONDON, Nov 1 (Reuters) - The one-month lockdown for England
announced by Prime Minister Boris Johnson this weekend could be
extended as Britain struggles to contain a second wave of the
COVID-19 pandemic, a senior cabinet member said on Sunday.

After resisting the prospect of a new national lockdown for
most of last month, Johnson announced on Saturday that new
restrictions across England would kick in after midnight on
Thursday morning and last until Dec. 2.

The United Kingdom, which has the biggest official death
toll in Europe from COVID-19, is grappling with more than 20,000
new coronavirus cases a day and scientists have warned a
worst-case scenario of 80,000 dead could be exceeded this
winter.

Asked if a lockdown could be extended beyond early December,
senior cabinet minister Michael Gove told Sky News: "Yes."

Britain has reported 46,717 COVID-19 deaths - defined as
those dying within 28 days of a positive test. A broader measure
of those with COVID-19 on their death certificates puts the toll
at 58,925.

"We can definitively say that unless we take action now, the
(health service) is going to be overwhelmed in ways that none of
us could countenance," Gove said.

The new lockdown announcement came 10 days after Johnson
told parliament it would "make no sense at all" to "turn the
lights out with a full national lockdown".

Critics have accused him of dithering at the expense of both
lives and the economy.

Opposition Labour Party leader Keir Starmer said the
government had missed a golden chance to lock down England more
effectively during a week-long school break at the end of
October.

"Well that's gone now. That is the price of the government's
incompetence," Starmer told the BBC.

The other parts of the United Kingdom - Scotland, Wales and
Northern Ireland - have their own policies and enacted tougher
COVID-19 health restrictions in recent weeks.

EXTRA FINANCIAL SUPPORT

Government scientific adviser Jeremy Farrar said on Sunday
the lockdown would need to be extended beyond early December
unless the epidemic was clearly shrinking.

"Much better to do that than remove these restrictions and
then have to reimpose even more draconian restrictions around
Christmas or soon into the new year," he told the BBC.

Farrar said he had high hopes vaccines would make a big
difference to the pandemic next year, even if they might not be
perfect.

British drugmaker AstraZeneca said on Sunday
Britain's health regulator had started an accelerated review of
its potential coronavirus vaccine.

Gove said the government would publish more information in
coming days about financial support for businesses and
households, including extending a scheme to pay most of the
salaries of furloughed workers, which had been due to end on
Oct. 31.

The new measures are likely to add substantially to the
roughly 200 billion pounds of emergency spending already
committed by finance minister Rishi Sunak.

JPMorgan estimated on Sunday that an extra 20 billion pounds
of government support will be provided to counter a 1.5% fall in
economic output in the fourth quarter - a combination that would
push the budget deficit to some 20% of gross domestic product.

Even before the latest lockdown announcement, a Reuters poll
of economists suggested the economy was on course to contract
10% this year, its worst performance since the early 1700s.

The survey showed the Bank of England is likely to announce
a 100 billion-pound expansion of its bond buying stimulus on
Thursday.
(Reporting by Andy Bruce; Editing by Angus MacSwan and Raissa
Kasolowsky)

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.